# Biopreservation Market

> Biopreservation Market Research Report By Application (Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, Regenerative Medicine), By Product Type (Biopreservation Media, Freezers, Cryogenic Storage Systems, Accessories), By End User (Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, Clinics), By Storage Type (Cryopreservation, Controlled Rate Freezing, Ultra-Low Temperature Storage) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 4.75%
- **2024:** $ 7.44 Billion
- **2025:** $ 7.79 Billion
- **2035:** $ 12.4 Billion
- **Key Players:** Thermo Fisher Scientific (US), Merck KGaA (DE), Sartorius AG (DE), Danaher Corporation (US), BioLife Solutions (US), Lonza Group (CH), Fujifilm Holdings Corporation (JP), Becton, Dickinson and Company (US), Charles River Laboratories (US)

**Report ID:** MRFR/HC/4946-HCR · **Pages:** 200 · **Author:** Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/biopreservation-market-6407

---

## Market Summary

## **Biopreservation Market Overview**

Biopreservation Market share register 7.44 Billion USD in 2024, projected to grow 4.75% CAGR during the forecast period (2025 - 2035). As per MRFR analysis, the Biopreservation Market Industry size is expected to grow from 7.1 Billion USD in 2023 to 12.4 Billion USD by 2035.

### **Key Biopreservation Market Trends Highlighted**

The growing demand for efficient techniques to preserve biological samples and cell-based products is fueling the Biopreservation Market. The demand for biopreservation solutions is being driven by a number of important causes, including the growing biobank investments and the growing biotechnology industry.

The market is expanding as a result of growing knowledge of the advantages of biopreservation in regenerative medicine and drug development. The effectiveness and safety of maintaining biological materials in a variety of healthcare applications are improved by emerging technology, such as sophisticated cryopreservation methods and the growth of biobanks. More research may be done on the opportunities in the Biopreservation Market.

The necessity for conserved biological samples to offer customized treatment options is being driven by the growing demand for personalized medicine. Additionally, developing nations are growing their healthcare systems, which presents a possible market for biopreservation products.

There are more opportunities for market participants to invest in new technologies and products that address these changing needs as a result of research organizations and academic institutions placing an increased emphasis on innovative approaches. Current trends show a move toward environmentally friendly biopreservation techniques that are in line with international environmental objectives. A deliberate attempt to lessen the environmental impact of biopreservation techniques is seen in advancements in biodegradable materials and energy-efficient storage options. Furthermore, there is a growing emphasis on creating specialized biopreservation solutions as a result of partnerships between pharmaceutical corporations and academic institutions.

In terms of safety, cost-effectiveness, and efficacy, this collaborative trend promotes a more successful strategy for developing biopreservation in the Biopreservation Market. The regulatory environment is changing, promoting adherence to strict quality standards and increasingly influencing the global use of biopreservation.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **Biopreservation Market Drivers**

### **Increasing Demand for Biobanks in Biopreservation Market**

According to a report from the European Biobanking and Biomolecular Resources Research Infrastructure (BBMRI), there has been a fourfold increase in biobanks globally over the last decade, with an estimated 10,000 biobanks in existence worldwide currently.

Biobanks are vital for research and development in personalized medicine, which is projected to reach a total market size of around USD 2.8 trillion by 2025. Moreover, organizations such as the National Institutes of Health (NIH) are investing heavily in biobanking initiatives, indicating a robust trend towards the utilization of preserved biological samples for research.

This surge in biobanking not only underscores the necessity of advanced biopreservation techniques but also highlights the potential for continued growth in the Biopreservation Market as these technologies become integral to biobank operations.

### **Rising Prevalence of Chronic Diseases**

The Biopreservation Market is significantly supported by the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular illnesses. The World Health Organization (WHO) reports that chronic diseases are responsible for approximately 71% of all global deaths annually, amounting to around 41 million nearly every year.

This alarming statistic emphasizes the increasing demand for effective treatments and therapies, necessitating robust biopreservation methods to sustain biological samples for research and drug development.

Biotechnology companies are adapting to these needs, highlighted by the investment strategies of organizations such as Amgen, which target chronic disease therapies. As a result, the Biopreservation Market is predicted to expand, fueled by the need for preserved samples crucial to combating the rise in chronic health issues.

### **Advancements in Biopreservation Technologies**

Technology innovations have notably propelled the Biopreservation Market. Newer methods, enhancements in cryopreservation, and the use of advanced cryoprotectants are continuously being researched and developed.

Recent patent filings from organizations such as BioLife Solutions and the National Institute of Standards and Technology (NIST) indicate an ongoing commitment to refining these technologies. For instance, BioLife Solutions reported an increase in their cryopreservation product sales by over 30% in the past year, showcasing the demand for innovative preservation solutions.

This technological advancement not only improves the viability of cellular and tissue samples but also attracts investments in the Biopreservation Market. Enhanced technologies provide companies a competitive edge, driving market growth as organizations strive to adopt superior techniques for biopreservation.

### **Regulatory Support for Biopreservation Practices**

The regulatory environment surrounding biopreservation practices has become increasingly favorable, contributing positively to the Biopreservation Market. Governments across various regions have implemented stringent guidelines to ensure the quality and safety of biopreserved materials.

In the United States, the Food and Drug Administration (FDA) has laid out clear regulations for cellular therapies and biopreservation processes, which have bolstered the public's trust and acceptance.

Furthermore, the Institute for Quality Management in Healthcare (IQMH) noted that compliance with these governmental regulations promotes the adoption of advanced biopreservation methods within clinical settings, particularly within biobanks and research laboratories.

This supportive regulatory landscape not only fosters market confidence but also encourages continuous investment and innovation in biopreservation technologies, driving the expected growth of the Biopreservation Market.

## **Biopreservation Market Segment Insights**

### **Biopreservation Market Application Insights**

The Biopreservation Market segmentation focusing on the Application aspect revealed significant insights into its structure and growth potential across several key areas. The overall market achieved a decent valuation, with distinct applications such as Cell and Tissue Culture, Gene and Drug Therapy, Clinical Applications, and Regenerative Medicine showcasing varying factors contributing to this growth.

Among these, the Cell and Tissue Culture application dominated the market with a notable valuation of 2.8 USD Billion in 2024, expanding further to 4.3 USD Billion by 2035, driven largely by the increasing demand for biopreserved tissues in therapeutic applications and research settings. This area was critical as it supported advancements in areas like cancer research and regenerative therapies, significantly affecting patient treatment outcomes.

Gene and Drug Therapy played a vital role, holding a market value of 1.8 USD Billion in 2024, and expected to grow to 3.0 USD Billion by 2035. This application became increasingly important due to breakthroughs in personalized medicine and the necessity for safe and effective storage of bio-specimens for innovative treatments.

Clinical Applications were valued at 2.34 USD Billion in 2024, projected to rise to 3.9 USD Billion by 2035, underlining the increasing reliance on biopreservation techniques to maintain the integrity of clinical samples and enhance the efficacy of diagnostic tests. Lastly, the Regenerative Medicine application, while comparatively smaller, with a valuation of 0.5 USD Billion in 2024 and anticipated growth to 1.2 USD Billion by 2035, represented an important frontier in medicine, reflecting the growing interest in stem cell therapies and tissue engineering solutions.

Together, these applications painted a comprehensive picture of the Biopreservation Market revenue, with each segment reflecting unique growth drivers and opportunities, alongside typical challenges like regulatory compliance and quality assurance. The overall Biopreservation Market Statistics indicated a robust and promising trajectory, responding to urgent healthcare needs and technological advancements within the industry, cementing its status as a significant contributor to modern medical practices and research endeavors.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

### **Biopreservation Market Product Type Insights**

Key categories within this market include Biopreservation Media, Freezers, Cryogenic Storage Systems, and Accessories, each playing a critical role in ensuring the effective preservation of biological materials. Biopreservation Media is integral for maintaining cell integrity during storage, while Freezers provide essential long-term storage solutions across various applications.

Cryogenic Storage Systems are particularly significant due to their ability to preserve cells, tissues, and organs at ultra-low temperatures, thereby ensuring viability for future use. Accessories, although often overlooked, support the functionality and efficiency of the primary systems.

The Biopreservation Market statistics showcase that advancements in technology and rising healthcare expenditures are major growth drivers. However, challenges, including stringent regulatory environments and high initial costs, may affect market dynamics.

Overall, the continuous evolution in the Biopreservation Market presents ample opportunities for innovation and growth, thereby solidifying its importance in the healthcare landscape.

### **Biopreservation Market End User Insights**

The Biopreservation Market shows considerable potential across various End User sectors, specifically encompassing Biotechnology Companies, Pharmaceutical Companies, Research Institutions, Hospitals, and Clinics. These End Users are positioned to significantly impact market growth. Biotechnology companies are central to the development and commercialization of biopreservation techniques, while Pharmaceutical companies leverage these methods for drug development and safety storage, reinforcing their dominance.

Research Institutions contribute to advancements through innovative methodologies and studies, ensuring the field remains adaptive and evolving. Hospitals and Clinics benefit from biopreservation methods to maintain biological samples and improve patient outcomes, thus holding a critical position in the healthcare continuum.

As growth drivers, increased demand for organ transplants and stem cell therapies intensify the necessity for effective biopreservation solutions across these sectors. The Biopreservation Market segmentation reveals these End Users as fundamental contributors, paving the way for improved strategies and methodologies, ultimately addressing the challenges and opportunities inherent in biopreservation practices on a global scale.

### **Biopreservation Market Storage Type Insights**

The Biopreservation Market revolves around various storage types, with advancements in technologies greatly influencing growth in this area. The storage type segment primarily includes Cryopreservation, Controlled Rate Freezing, and Ultra-Low Temperature Storage, each playing a crucial role in preserving biological materials.

Cryopreservation is pivotal for long-term storage of cells and tissues, contributing significantly to Research and Development in regenerative medicine and cell therapy. Controlled Rate Freezing, on the other hand, ensures that cells remain viable during the freezing process, thus preventing ice crystal formation and related damage.

Ultra-Low Temperature Storage enables the safe preservation of sensitive biological components, maintaining their integrity over extended periods. Together, these storage types addressed the growing needs of the pharmaceutical and biotechnology industries, driven by the increasing demand for biobanks and other related services.

### **Biopreservation Market Regional Insights**

The Biopreservation Market showed significant regional variations, with North America holding the largest share valued at 3.0 USD Billion in 2024 and projected to grow to 5.0 USD Billion by 2035, primarily driven by technological advancements and a well-established healthcare infrastructure.

Europe followed with a valuation of 2.0 USD Billion in 2024, expected to reach 3.5 USD Billion in 2035, reflecting a robust demand for biopreservation solutions amidst stringent regulatory standards. The APAC region, valued at 1.5 USD Billion in 2024 and 2.5 USD Billion in 2035, expanded rapidly due to increasing investments in healthcare and rising awareness of biopreservation techniques.

South America, with an initial valuation of 0.6 USD Billion in 2024, is projected to grow to 1.0 USD Billion by 2035, driven by improvements in health infrastructure and research initiatives. The Middle East and Africa (MEA) market, though smaller at 0.34 USD Billion in 2024, anticipates growth to 0.4 USD Billion by 2035, backed by government support for healthcare innovations. These figures underlined the diverse opportunities within the Biopreservation Market, where regional demands shape market growth and development.

Source: Primary Research, Secondary Research, MRFR Database and Analyst Review

## **Biopreservation Market Key Players and Competitive Insights**

The Biopreservation Market is characterized by a rapidly evolving landscape, marked by increasing demand for biopreserved materials across various sectors, particularly in pharmaceuticals, biotechnology, and healthcare. As organizations strive to ensure the longevity and stability of biological samples, the competition among leading players intensifies.

Technological advancements in cryopreservation, liquid nitrogen storage, and bio-banking solutions are pivotal in shaping the market dynamics. Companies are continuously innovating their product offerings, expanding their service capabilities, and establishing strategic partnerships to enhance their position in the market.

The interplay between regional developments and global trends plays a significant role in influencing competitive strategies, with manufacturers focusing heavily on research and development to address the challenges of maintaining sample integrity.

Panasonic Healthcare stands as a significant competitor in the Biopreservation Market, leveraging its expertise in advanced cold storage solutions. The company’s offerings include a range of refrigerators and freezers specifically designed for biopreservation applications, playing a critical role in preserving biological materials.

With a strong emphasis on cutting-edge technology, Panasonic Healthcare ensures the reliability and efficiency of its products, ultimately supporting the healthcare and pharmaceutical industries in maintaining the quality of their samples.

Their global presence, strengthened by extensive distribution networks and partnerships, allows Panasonic Healthcare to cater to a diverse clientele, from research institutions to large-scale pharmaceutical companies. The company’s commitment to innovation, coupled with its robust customer support framework, reinforces its competitive edge in this dynamic market.

Fujifilm Irvine Scientific plays a crucial role in the Biopreservation Market by providing tailored solutions for cell culture and biopreservation needs. The company specializes in advanced cell therapies and media formulations that are essential for biopreservation and regenerative medicine.

With a strong focus on innovation, Fujifilm Irvine Scientific continues to develop key products that enhance the quality and efficacy of biopreserved cells and tissues. Their strategic mergers and acquisitions have bolstered their position, allowing for the integration of new technologies and expanding their product portfolio.

As a result, Fujifilm Irvine Scientific has established a solid market presence, catering to both research and clinical applications globally. The company’s strengths lie in its ability to deliver high-quality products while maintaining compliance with international regulatory standards, making it a trusted partner in the biopreservation sector.

### **Key Companies in the Biopreservation Market Include**

- Biolife Solutions
- Panasonic Healthcare
- Fujifilm
- Sartorius AG
- [Thermo Fisher Scientific](https://www.thermofisher.com/us/en/home/order/new-products.html)
- SigmaAldrich
- Lonza
- Merck KGaA
- Cryoport

### Biopreservation Market Developments

- **Q2 2024: BioLife Solutions Announces Opening of New Biopreservation Media Manufacturing Facility in Bothell, Washington** BioLife Solutions opened a new state-of-the-art manufacturing facility in Bothell, Washington, to expand production capacity for its biopreservation media products, supporting increased demand from cell and gene therapy customers.
- **Q2 2024: Thermo Fisher Scientific Launches New CryoStor® CS10 Biopreservation Solution for Cell Therapy Applications** Thermo Fisher Scientific introduced CryoStor® CS10, a new biopreservation solution designed to enhance post-thaw cell viability for cell therapy developers and manufacturers.
- **Q1 2024: Panasonic Healthcare Unveils Next-Generation Ultra-Low Temperature Freezer for Biopreservation** Panasonic Healthcare launched a new ultra-low temperature freezer model aimed at improving the reliability and energy efficiency of biopreservation for research and clinical applications.
- **Q2 2024: BioCision Announces Strategic Partnership with Cryoport to Advance Biopreservation Logistics** BioCision entered into a strategic partnership with Cryoport to integrate BioCision’s biopreservation technologies with Cryoport’s logistics solutions, aiming to improve the transport and storage of temperature-sensitive biological materials.
- **Q1 2024: VWR International Expands Biopreservation Product Portfolio with Launch of New Storage Media** VWR International launched a new line of biopreservation storage media, targeting biobanking and regenerative medicine customers seeking improved sample viability.
- **Q2 2024: BioLife Solutions Appoints New Chief Operating Officer to Lead Biopreservation Business Expansion** BioLife Solutions appointed a new Chief Operating Officer to oversee the company’s biopreservation business, focusing on scaling operations and supporting global growth.
- **Q1 2024: Thermo Fisher Scientific Receives CE Mark for Biopreservation Media for Use in European Cell Therapy Manufacturing** Thermo Fisher Scientific received CE Mark approval for its biopreservation media, enabling its use in cell therapy manufacturing across the European Union.
- **Q2 2024: BioCision Secures $20 Million Series C Funding to Accelerate Biopreservation Technology Development** BioCision raised $20 million in Series C funding to support the development and commercialization of advanced biopreservation technologies for the life sciences sector.
- **Q1 2024: Panasonic Healthcare Partners with Leading Biobank to Supply Biopreservation Equipment** Panasonic Healthcare entered into a partnership with a major biobank to supply ultra-low temperature freezers and related biopreservation equipment for long-term biological sample storage.
- **Q2 2024: BioLife Solutions Acquires Custom Biogenic Systems to Expand Biopreservation Product Offerings** BioLife Solutions acquired Custom Biogenic Systems, a manufacturer of cryogenic storage equipment, to broaden its biopreservation solutions portfolio.
- **Q1 2024: Thermo Fisher Scientific Announces Contract to Supply Biopreservation Media to Major Cell Therapy Manufacturer** Thermo Fisher Scientific signed a contract to supply its biopreservation media to a leading cell therapy manufacturer, supporting large-scale production of cell-based therapies.
- **Q2 2024: BioCision Launches New Modular Biopreservation Platform for Clinical Trial Sample Management** BioCision launched a modular biopreservation platform designed to streamline the management and storage of clinical trial samples, enhancing sample integrity and traceability.

## **Biopreservation Market Segmentation Insights**

### **Biopreservation Market Application Outlook**

- Cell and Tissue Culture
- Gene and Drug Therapy
- Clinical Applications
- Regenerative Medicine

### **Biopreservation Market Product Type Outlook**

- Biopreservation Media
- Freezers
- Cryogenic Storage Systems
- Accessories

### **Biopreservation Market End User Outlook**

- Biotechnology Companies
- Pharmaceutical Companies
- Research Institutions
- Hospitals
- Clinics

### **Biopreservation Market Storage Type Outlook**

- Cryopreservation
- Controlled Rate Freezing
- Ultra-Low Temperature Storage

### **Biopreservation Market Regional Outlook**

- North America
- Europe
- South America
- Asia Pacific
- Middle East and Africa

## Market Drivers

### Growing Awareness of Food Safety

The Biopreservation Market is increasingly shaped by the growing awareness of food safety among consumers and manufacturers alike. As foodborne illnesses remain a significant concern, there is a heightened focus on ensuring the safety and quality of food products. Biopreservation Market techniques, which utilize natural antimicrobial agents, are gaining traction as effective solutions to extend shelf life while maintaining product integrity. Market data suggests that the demand for biopreservation in the food sector is expected to rise, driven by consumer preferences for clean label products. This trend is likely to encourage food manufacturers to adopt biopreservation methods, thereby expanding the market. The emphasis on food safety is expected to foster innovation in biopreservation technologies, leading to the development of new solutions that address consumer concerns.

### Regulatory Support for Biopreservation

The Biopreservation Market is benefiting from increasing regulatory support aimed at promoting safer and more effective preservation methods. Regulatory bodies are recognizing the importance of biopreservation in ensuring food safety and pharmaceutical efficacy. This support is reflected in the establishment of guidelines that encourage the use of biopreservation techniques, which are often viewed as more sustainable compared to traditional methods. For instance, regulations that favor natural preservatives over synthetic alternatives are likely to enhance market growth. Furthermore, as governments focus on public health and safety, the biopreservation market is expected to receive additional backing, potentially leading to a more favorable environment for innovation and investment in biopreservation technologies.

### Rising Demand for Personalized Medicine

The Biopreservation Market is experiencing a surge in demand for [personalized medicine](https://www.marketresearchfuture.com/reports/personalized-medicine-market-2937), which is significantly influencing the biopreservation landscape. As healthcare shifts towards tailored treatments, the need for effective preservation of biological samples, such as tissues and cells, becomes paramount. This trend is supported by the increasing number of biobanks and research institutions focusing on personalized therapies. The biopreservation market is projected to expand as these institutions require reliable methods to store and preserve biological materials. The growth of personalized medicine is expected to drive innovations in biopreservation techniques, ensuring that samples remain viable for research and therapeutic applications. This evolving demand may lead to a more robust market, with companies developing specialized solutions to meet the unique needs of personalized medicine.

### Technological Innovations in Biopreservation

The Biopreservation Market is significantly influenced by ongoing technological innovations that enhance preservation methods. Advances in cryopreservation, for instance, are enabling more effective storage of biological materials, which is crucial for both research and clinical applications. Technologies such as automated storage systems and improved cryoprotectants are being developed to optimize the preservation process. These innovations not only improve the viability of preserved samples but also reduce costs associated with storage and handling. As technology continues to evolve, the biopreservation market is likely to see an influx of new products and services that cater to the growing needs of various sectors, including healthcare and food industries. This technological momentum may lead to increased efficiency and effectiveness in biopreservation practices.

### Increasing Adoption of Biopreservation Techniques

The Biopreservation Market is witnessing a notable increase in the adoption of biopreservation techniques across various sectors, particularly in pharmaceuticals and food preservation. This trend is driven by the need for enhanced shelf life and safety of products. According to recent data, the biopreservation market is projected to grow at a compound annual growth rate of approximately 12% over the next few years. This growth is attributed to the rising awareness of the benefits of biopreservation, including reduced reliance on chemical preservatives and improved product quality. As consumers become more health-conscious, the demand for natural preservation methods is likely to rise, further propelling the biopreservation market. Companies are increasingly investing in research and development to innovate and improve biopreservation methods, which may lead to more effective solutions in the industry.

## Future Outlook

The Biopreservation Market is projected to grow at a 4.75% CAGR from 2025 to 2035, driven by advancements in preservation technologies and increasing demand for biopharmaceuticals.

**New opportunities:**

- Development of advanced cryopreservation solutions for cell therapies. Integration of IoT for real-time monitoring of biopreservation conditions. Expansion of biopreservation services in emerging markets.

By 2035, the Biopreservation Market is expected to achieve substantial growth, reflecting evolving industry needs.

## Segment Insights

### By Application: Cell and Tissue Culture (Largest) vs. Regenerative Medicine (Fastest-Growing)

The Biopreservation Market is diverse, with significant contributions from various applications. Among these, Cell and Tissue Culture holds the largest market share, driven by its essential role in research and development in biopharmaceuticals. Clinical Applications also contribute notably, focusing on FDA-approved therapies, while Gene and Drug Therapy vies for market space, primarily fueled by advancements in personalized medicine. In the realm of growth trends, [Regenerative Medicine](https://www.marketresearchfuture.com/reports/regenerative-medicine-market-2220) is recognized as the fastest-growing segment, with rising investments and advancements in technologies enhancing cellular therapies. This growth is propelled by an increase in the incidence of chronic diseases, the aging population, and an emphasis on innovation in tissue engineering, which is shaping the future of healthcare applications across various sectors.

Cell and Tissue Culture: Dominant vs. Gene and Drug Therapy: Emerging

Cell and Tissue Culture serves as the dominant application in the Biopreservation Market, primarily due to its established role in supporting research in cellular therapies and vaccine production. This application is foundational for growing cell lines, which are critical for therapeutic development. In contrast, Gene and Drug Therapy is emerging as a significant player, leveraging innovations in genetic engineering and biotechnology. This segment is underpinned by the need for personalized treatments and the ongoing drive for novel drug development. Together, these applications illustrate the dynamic landscape of the market, where established practices coexist with transformative advancements aimed at addressing unmet medical needs.

### By Product Type: Biopreservation Media (Largest) vs. Freezers (Fastest-Growing)

In the Biopreservation Market, the distribution of market share among product types reveals that Biopreservation Media holds the largest share, significantly contributing to the overall growth of this sector. Freezers, while not as dominant, are witnessing an impressive surge, driven by the increasing demand for reliable storage solutions in research, clinical applications, and biobanking. The competitive landscape is characterized by a focus on innovative technologies and improved storage capabilities that enhance the viability of biological samples. The growth trends in this segment are primarily fueled by advancements in biopreservation technologies and the rising emphasis on regenerative medicine and personalized therapies. Organizations are investing in robust biopreservation solutions to ensure the integrity and longevity of biological materials during storage and transport. Moreover, the emergence of new applications in biotechnology and pharmaceuticals is expected to drive the demand for both Freezers and Biopreservation Media, indicating a shift towards more comprehensive and efficient storage solutions.

Biopreservation Media (Dominant) vs. Cryogenic Storage Systems (Emerging)

Biopreservation Media is currently positioned as the dominant force in the Biopreservation Market, with its widespread use in various applications ranging from cellular therapies to drug development. It provides essential nutrients and growth factors that preserve the viability of biological samples, ensuring their efficacy during storage. In contrast, Cryogenic Storage Systems are emerging as a vital segment, gaining traction due to their ability to maintain biological materials at ultra-low temperatures. This technology is becoming increasingly important for applications requiring long-term storage and preservation of sensitive biological samples such as stem cells and reproductive cells. The synergy between these two product types is critical as they collectively enhance the functionality of biopreservation solutions and cater to the evolving needs of the biopharmaceutical and research communities.

### By End User: Biotechnology Companies (Largest) vs. Pharmaceutical Companies (Fastest-Growing)

The biopreservation market shows a diverse distribution among its key end users, which include biotechnology companies, pharmaceutical companies, research institutions, hospitals, and clinics. Biotechnology companies currently hold the largest share in this market, driven by their reliance on biopreservation techniques to ensure the viability of biological materials. Pharmaceutical companies, while smaller in market share, are rapidly increasing their adoption of biopreservation solutions as they seek to enhance drug development processes and preserve sensitive biological components.

Biotechnology Companies (Dominant) vs. Pharmaceutical Companies (Emerging)

Biotechnology companies are viewed as the dominant players in the biopreservation market, leveraging advanced technologies to ensure the integrity and stability of biomaterials. These companies often engage in extensive research and development activities, resulting in a robust demand for biopreservation solutions that maintain the quality of biological samples. In contrast, pharmaceutical companies are emerging as significant users of biopreservation technologies. They are expanding their investments in this area to enhance drug discovery and development workflows. This trend is indicative of the growing importance of biopreservation in safeguarding the efficacy of therapeutics, as these companies recognize the need for reliable preservation methods to support their operations.

### By Storage Type: Cryopreservation (Largest) vs. Ultra-Low Temperature Storage (Fastest-Growing)

In the Biopreservation Market, the storage type segment is characterized by distinct applications, with cryopreservation holding the largest market share due to its critical role in preserving biological materials such as stem cells and reproductive cells. Controlled Rate Freezing follows, offering a reliable method for preserving cells while minimizing ice crystal formation. Ultra-Low Temperature Storage is also significant, increasingly gaining traction as more organizations adopt advanced cooling technologies for long-term storage of sensitive biological samples.

Cryopreservation (Dominant) vs. Ultra-Low Temperature Storage (Emerging)

Cryopreservation is the dominant storage method in the biopreservation market, well-regarded for its effectiveness in preserving a wide range of biological samples at very low temperatures. This technique minimizes cellular damage and is crucial for applications in regenerative medicine and fertility treatments. Conversely, Ultra-Low Temperature Storage is emerging as a vital alternative, driven by the growing demand for safe and effective long-term storage solutions. The advancement of cooling technologies allows for better preservation of sensitive materials, such as pharmaceuticals and biologics, making it an appealing option for research and clinical applications. As both segments evolve, they reflect the broader trends towards efficiency and reliability in biopreservation.

## Regional Market Share Analysis

The Biopreservation Market showed significant regional variations, with North America holding the largest share valued at 3.0 USD Billion in 2024 and projected to grow to 5.0 USD Billion by 2035, primarily driven by technological advancements and a well-established healthcare infrastructure.

Europe followed with a valuation of 2.0 USD Billion in 2024, expected to reach 3.5 USD Billion in 2035, reflecting a robust demand for biopreservation solutions amidst stringent regulatory standards. The APAC region, valued at 1.5 USD Billion in 2024 and 2.5 USD Billion in 2035, expanded rapidly due to increasing investments in healthcare and rising awareness of biopreservation techniques.

South America, with an initial valuation of 0.6 USD Billion in 2024, is projected to grow to 1.0 USD Billion by 2035, driven by improvements in health infrastructure and research initiatives. The Middle East and Africa (MEA) market, though smaller at 0.34 USD Billion in 2024, anticipates growth to 0.4 USD Billion by 2035, backed by government support for healthcare innovations. These figures underlined the diverse opportunities within the Biopreservation Market, where regional demands shape market growth and development.

## Competitive Benchmarking

The Biopreservation Market is characterized by a rapidly evolving landscape, marked by increasing demand for biopreserved materials across various sectors, particularly in pharmaceuticals, biotechnology, and healthcare. As organizations strive to ensure the longevity and stability of biological samples, the competition among leading players intensifies. Technological advancements in cryopreservation, liquid nitrogen storage, and bio-banking solutions are pivotal in shaping the market dynamics. Companies are continuously innovating their product offerings, expanding their service capabilities, and establishing strategic partnerships to enhance their position in the market. The interplay between regional developments and global trends plays a significant role in influencing competitive strategies, with manufacturers focusing heavily on research and development to address the challenges of maintaining sample integrity. Panasonic Healthcare stands as a significant competitor in the Biopreservation Market, leveraging its expertise in advanced cold storage solutions. The company’s offerings include a range of refrigerators and freezers specifically designed for biopreservation applications, playing a critical role in preserving biological materials. With a strong emphasis on cutting-edge technology, Panasonic Healthcare ensures the reliability and efficiency of its products, ultimately supporting the healthcare and pharmaceutical industries in maintaining the quality of their samples. Their global presence, strengthened by extensive distribution networks and partnerships, allows Panasonic Healthcare to cater to a diverse clientele, from research institutions to large-scale pharmaceutical companies. The company’s commitment to innovation, coupled with its robust customer support framework, reinforces its competitive edge in this dynamic market. Fujifilm Irvine Scientific plays a crucial role in the Biopreservation Market by providing tailored solutions for cell culture and biopreservation needs. The company specializes in advanced cell therapies and media formulations that are essential for biopreservation and regenerative medicine. With a strong focus on innovation, Fujifilm Irvine Scientific continues to develop key products that enhance the quality and efficacy of biopreserved cells and tissues. Their strategic mergers and acquisitions have bolstered their position, allowing for the integration of new technologies and expanding their product portfolio. As a result, Fujifilm Irvine Scientific has established a solid market presence, catering to both research and clinical applications globally. The company’s strengths lie in its ability to deliver high-quality products while maintaining compliance with international regulatory standards, making it a trusted partner in the biopreservation sector.

## Recent News & Developments

- **Q2 2024: BioLife Solutions Announces Opening of New Biopreservation Market Media Manufacturing Facility in Bothell, Washington** BioLife Solutions opened a new state-of-the-art manufacturing facility in Bothell, Washington, to expand production capacity for its biopreservation media products, supporting increased demand from cell and gene therapy customers.
- **Q2 2024: Thermo Fisher Scientific Launches New CryoStor® CS10 Biopreservation Market Solution for [Cell Therapy](https://www.marketresearchfuture.com/reports/cell-therapy-market-5066) Applications** Thermo Fisher Scientific introduced CryoStor® CS10, a new biopreservation solution designed to enhance post-thaw cell viability for cell therapy developers and manufacturers.
- **Q1 2024: Panasonic Healthcare Unveils Next-Generation Ultra-Low Temperature Freezer for Biopreservation Market** Panasonic Healthcare launched a new ultra-low temperature freezer model aimed at improving the reliability and energy efficiency of biopreservation for research and clinical applications.
- **Q2 2024: BioCision Announces Strategic Partnership with Cryoport to Advance Biopreservation Market Logistics** BioCision entered into a strategic partnership with Cryoport to integrate BioCision’s biopreservation technologies with Cryoport’s logistics solutions, aiming to improve the transport and storage of temperature-sensitive biological materials.
- **Q1 2024: VWR International Expands Biopreservation Market Product Portfolio with Launch of New Storage Media** VWR International launched a new line of biopreservation storage media, targeting biobanking and regenerative medicine customers seeking improved sample viability.
- **Q2 2024: BioLife Solutions Appoints New Chief Operating Officer to Lead Biopreservation Market Business Expansion** BioLife Solutions appointed a new Chief Operating Officer to oversee the company’s biopreservation business, focusing on scaling operations and supporting global growth.
- **Q1 2024: Thermo Fisher Scientific Receives CE Mark for Biopreservation Market Media for Use in European Cell Therapy Manufacturing** Thermo Fisher Scientific received CE Mark approval for its biopreservation media, enabling its use in cell therapy manufacturing across the European Union.
- **Q2 2024: BioCision Secures $20 Million Series C Funding to Accelerate Biopreservation Market Technology Development** BioCision raised $20 million in Series C funding to support the development and commercialization of advanced biopreservation technologies for the life sciences sector.
- **Q1 2024: Panasonic Healthcare Partners with Leading Biobank to Supply Biopreservation Market Equipment** Panasonic Healthcare entered into a partnership with a major biobank to supply ultra-low temperature freezers and related biopreservation equipment for long-term biological sample storage.
- **Q2 2024: BioLife Solutions Acquires Custom Biogenic Systems to Expand Biopreservation Market Product Offerings** BioLife Solutions acquired Custom Biogenic Systems, a manufacturer of cryogenic storage equipment, to broaden its biopreservation solutions portfolio.
- **Q1 2024: Thermo Fisher Scientific Announces Contract to Supply Biopreservation Market Media to Major Cell Therapy Manufacturer** Thermo Fisher Scientific signed a contract to supply its biopreservation media to a leading cell therapy manufacturer, supporting large-scale production of cell-based therapies.
- **Q2 2024: BioCision Launches New Modular Biopreservation Market Platform for Clinical Trial Sample Management** BioCision launched a modular biopreservation platform designed to streamline the management and storage of clinical trial samples, enhancing sample integrity and traceability.

## Report Scope

| MARKET SIZE 2024 | 7.44(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 7.793(USD Billion) |
| MARKET SIZE 2035 | 12.4(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 4.75% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Thermo Fisher Scientific (US), Merck KGaA (DE), Sartorius AG (DE), Danaher Corporation (US), BioLife Solutions (US), Lonza Group (CH), Fujifilm Holdings Corporation (JP), Becton, Dickinson and Company (US), Charles River Laboratories (US) |
| Segments Covered | Application, Product Type, End User, Storage Type, Regional |
| Key Market Opportunities | Advancements in microbial preservation techniques enhance product shelf life in the Biopreservation Market. |
| Key Market Dynamics | Rising demand for biopreservation techniques driven by regulatory changes and technological advancements in food and pharmaceutical sectors. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Biopreservation Market as of 2024?**
A: The Biopreservation Market was valued at 7.44 USD Billion in 2024.

**Q: What is the projected market size for the Biopreservation Market in 2035?**
A: The market is projected to reach 12.4 USD Billion by 2035.

**Q: What is the expected CAGR for the Biopreservation Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Biopreservation Market during 2025 - 2035 is 4.75%.

**Q: Which application segment is anticipated to grow the most in the Biopreservation Market?**
A: The Clinical Applications segment is expected to grow from 2.0 USD Billion in 2024 to 3.0 USD Billion by 2035.

**Q: What are the key product types in the Biopreservation Market?**
A: Key product types include Biopreservation Media, Freezers, Cryogenic Storage Systems, and Accessories.

**Q: How much is the Biopreservation Media segment projected to be worth by 2035?**
A: The Biopreservation Media segment is projected to reach 4.0 USD Billion by 2035.

**Q: Which end-user segment is likely to see significant growth in the Biopreservation Market?**
A: Pharmaceutical Companies are expected to grow from 2.0 USD Billion in 2024 to 3.0 USD Billion by 2035.

**Q: What storage type is projected to have the highest valuation in the Biopreservation Market by 2035?**
A: Ultra-Low Temperature Storage is projected to reach 5.07 USD Billion by 2035.

**Q: Who are the leading companies in the Biopreservation Market?**
A: Key players include Thermo Fisher Scientific, Merck KGaA, Sartorius AG, and Danaher Corporation.

**Q: What is the growth outlook for the Cryopreservation segment in the Biopreservation Market?**
A: The Cryopreservation segment is expected to grow from 2.5 USD Billion in 2024 to 4.1 USD Billion by 2035.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/biopreservation-market-6407*